# Immunological biomarkers at birth and later risk of celiac disease

**Authors:** Maria Ulnes, Veroniqa Lundbäck, Susanne Lindgren, Mattias Molin, Rolf H. Zetterström, Olov Ekwall, Karl Mårild

PMC · DOI: 10.1186/s12876-025-03743-z · 2025-03-11

## TL;DR

This study found no link between immune cell profiles at birth and later development of celiac disease in children.

## Contribution

The study is the first to show that early immune markers do not predict childhood-onset celiac disease.

## Key findings

- No associations were found between T- and B-cell markers at birth and celiac disease development.
- Median percentages of T and B cells were similar between children with celiac disease and controls.
- Results remained consistent across different subgroups like sex, HLA type, and age at diagnosis.

## Abstract

The role of immune cell profiles at birth in determining the risk of celiac disease (CD) development is currently unestablished. This study aimed to determine the associations between T- and B-cell profiles at birth and pediatric CD.

This regional cohort study analyzed prospectively collected dried blood spots from 158 children with CD (median 7 years old at CD diagnosis) and two matched comparators each (n = 316). We quantified T-cell receptor excision circles (TRECs) and kappa-deleting recombination excision circles (KRECs) as measures of thymic and bone marrow output at birth. Moreover, we used epigenetic cell counting to estimate the percentages of lymphocyte subsets: CD3+, CD4+, CD8 + T cells, CD4 + memory T, regulatory T, B, and NK cells.

No associations were found between measured immune cell markers at birth and CD development (all p values > 0.26). The median number of copies was 120 for TRECs (IQR = 92–168) and 136 (IQR = 91–183) for CD patients and comparators, respectively, and for KRECs, it was 69 (IQR = 45–100) for CD patients and 66 for comparators (IQR = 44–93). Across the groups, there were similar median percentages of T cells (CD, 32.6% [IQR = 27.0–43.8%] vs. comparators, 33.9% [IQR = 26.3–45.7%]) and B cells (CD, 25.4% [IQR = 20.3–30.6%] vs. comparators, 24.7% [IQR = 19.9–30.8%]). The ratio of the lymphocyte subset estimates between CD patients and comparators approximated one; all p values were > 0.26. The results were consistent across strata defined by sex, HLA type, and age at diagnosis.

Genetic and epigenetic markers for B cells and T cells in immune cell profiles at birth did not impact susceptibility to childhood-onset CD.

The online version contains supplementary material available at 10.1186/s12876-025-03743-z.

## Linked entities

- **Diseases:** celiac disease (MONDO:0005130)

## Full-text entities

- **Genes:** HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}
- **Diseases:** CD (MESH:D002446)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11899458/full.md

---
Source: https://tomesphere.com/paper/PMC11899458